WASHINGTON, D.C. – The Advanced Medical Technology Association® announced today that its member respiratory device companies have dramatically expanded the limits of their present production capacity in responding to the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statements by Scott Whitaker, AdvaMed® president and CEO, and Susan Van Meter, executive director of AdvaMedDx®, regarding the medtech…
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today sent a letter to the Federal Emergency Management Agency (FEMA) and the administration calling for centralization of procurement and allocation decision-making for medical ventilators…
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19).
WASHINGTON, D.C. – FDA Commissioner Dr. Stephen Hahn joined a special meeting of AdvaMed®’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…